Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China flag China · Delayed Price · Currency is CNY
25.02
-0.50 (-1.96%)
Nov 16, 2026, 3:00 PM CST

SHA:603334 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
133.76140.55123.82129.71133.35101.91
Depreciation & Amortization
30.5930.5919.6118.1412.2510.24
Other Amortization
1.311.312.252.271.50.29
Loss (Gain) From Sale of Assets
-0.03-0.03-0.05-0.020.060.41
Asset Writedown & Restructuring Costs
0.410.410.060.761.71.63
Loss (Gain) From Sale of Investments
-1.02-1.02-0.73.985.07-
Provision & Write-off of Bad Debts
2.82.84.56-3.171.92.11
Other Operating Activities
102.610.732.6810.88-2.863.12
Change in Accounts Receivable
-24.86-24.86-118.1966.43-92.78-84.3
Change in Inventory
-283.21-283.21-44.27-96.7313.559.96
Change in Accounts Payable
103.51103.5132.811.4736.2141.85
Change in Other Net Operating Assets
-3.58-3.583.2828.86-40.24-6.7
Operating Cash Flow
58.64-26.4422.43162.569.7276.95
Operating Cash Flow Growth
---86.20%133.07%-9.40%2.77%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-26.86-24.36-79.53-168.11-80.1-71.94
Sale of Property, Plant & Equipment
0.370.190.170.180.360.52
Investment in Securities
-484.08-300-0.180.02-2.3
Other Investing Activities
6.310.90.440.34-7.421.31
Investing Cash Flow
-504.26-323.27-78.92-167.41-87.14-72.41

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-28.617.340.48--
Long-Term Debt Issued
-371.5315.2248.98328.57164.9
Total Debt Issued
338.11400.11322.54249.46328.57164.9
Long-Term Debt Repaid
--438.99-247-250.29-221.16-124.9
Lease Payments
-2.84-2.84-4.15-5-1.71-
Net Debt Issued (Repaid)
-125.32-38.8875.54-0.83107.440
Issuance of Common Stock
798.38795.44--14.1-
Common Dividends Paid
-55.05-10.35-10.63-25.37-22-3.87
Other Financing Activities
2.09----1.49-0.34
Financing Cash Flow
620.09746.2164.91-26.298.0135.79

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-12.56-0.14.652.9410.34-1.86
Net Cash Flow
161.91396.413.07-28.1890.9338.47

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
31.78-50.8-57.1-5.62-10.385.01
Free Cash Flow Growth
------91.49%
Free Cash Flow Margin
0.72%-1.60%-2.93%-0.33%-0.61%0.39%
Free Cash Flow Per Share
0.23-0.45-0.53-0.05-0.100.05
Levered Free Cash Flow
-2.9-104.73-148.93-84.8348.871.9
Unlevered Free Cash Flow
0.19-99.92-145.18-80.3852.83.99
Free Cash Flow After Leases
28.94-53.64-61.25-10.61-12.15.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
103.1567.5-10.3648.8443.2741.59
Change in Working Capital
-211.78-211.78-129.79-0.07-83.25-42.76